To investigate whether MYO1G promoter methylation and gene expression could predict the prognosis of melanoma, we stratified the 358 metastatic SKCM into two group (high and low groups) based on Beta values of four CpG sites and FPKM of MYO1G respectively, and correlated the two groups with overall survival. This evidence concerns the gene MYO1G and melanoma.